The ongoing tariff war continues to create uncertainty for investors, with a trade embargo between the US and China. Although Europe has received a temporary reprieve, the prolonged situation could result in significant economic damage. We are maintaining a defensive stance in our Benelux Dynamic Top Pick List, as the Federal Reserve holds steady and the European Central Bank may continue lowering rates. Pessimism regarding the European industry has increased, though some US-based European compa...
Greenyard's founding Deprez family, together with US investment management firm Solum Partners, are launching a takeover bid on Greenyard at €7.40 per share. A total of 67% of the shares, held by the Hein Deprez family and related parties, Greenyard and other strategic shareholders, have been committed to tender. Although we believe the timing of the offer is opportunistic, in our view it has a high probability of success, considering near-term uncertainties linked to the current trading environ...
Vopak reported 1Q25 which were in line with proportional EBITDA of €300m vs consensus of €292m. So far company foresees only limited impact in the short term linked to trade tariff uncertainty. EBITDA outlook maintained even when discounting less favourable FX rates. Indian AVTL on track for IPO in 1H25 following conditional approval by regulator. Occupancy rates holding up well at 92% vs. 93% last quarter. The Q&A in the analyst call further comforted our scenario. We reiterate Buy rating and €...
Resolutions passed by Vopak’s Annual General Meeting Resolutions passed by Vopak’s Annual General MeetingRotterdam, the Netherlands, 23 April 2025 The Annual General Meeting of Koninklijke Vopak N.V. (Royal Vopak) held on 23 April 2025 passed the following resolutions: Positive advisory vote implementation remuneration policy for the 2024 financial year. Adoption of the financial statements for the 2024 financial year. Approval of the proposed dividend. A dividend of EUR 1.60 per ordinary share with a nominal value of EUR 0.50 will be distributed wholly in cash on 2 May 2025. As fro...
AkzoNobel: 3% beat on 1Q25 Adj. EBITDA, FY25 guidance maintained at +€1.55bn. BE Semiconductor Industries: 1Q25 results - extending the downcycle. Corbion: Apogee. Just Eat Takeaway.com: 1Q25 Trading Update - no impact on the bid. Kinepolis: 1Q25 preview. KPN: 1Q25 preview. Randstad: Strong 9% high quality beat on 1Q25, 2Q25 outlook looks a touch below. Vår Energi: Fine start of the year, more to come. Vopak: Reasonable start, cashflow developing nicely.
Vopak reports strong Q1 2025 results, commissioning capacity in existing locations The Netherlands, 23 April 2025Vopak reports strong Q1 2025 results, commissioning capacity in existing locations Key highlights Q1 2025 Improve Net profit -including exceptional items- Q1 2025 of EUR 100 million and EPS of EUR 0.85 Proportional EBITDA -excluding exceptional items1- increased in Q1 2025 by EUR 23 million to EUR 300 million Agreements were signed for a new debt issuance of around EUR 560 million equivalent, improving Vopak's debt maturity profile and financial flexibility Grow Expandi...
Ackermans & van Haaren: Another Delen Private Bank acquisition in the Netherlands. Ahold Delhaize: Peer Albertsons FY24/25 results. ASML: 1Q25 results; already weaker ahead of the tariffs. Barco: Calm before the storm. Heineken: In the hold. Melexis: Partial move to China. Staffing sector: Hays' 3Q24/25 trading update; in line. Vopak: New industrial terminal or energy transition facility? WDP: €60m investment with KDL
A director at JOST Werke SE bought 650 shares at 47.000EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Vopak signs agreements for a new debt issuance of around EUR 560 million equivalent Vopak signs agreements for a new debt issuance of around EUR 560 million equivalentRotterdam, the Netherlands, 11th April 2025Royal Vopak announces the signing of Note Purchase Agreements for a debt issuance in the US Private Placement (USPP) market for a total amount of USD 325 million and EUR 260 million. Funding will take place in June 2025 and is subject to customary closing conditions.This Notes Program consists of various EUR and USD tranches with maturities ranging from 5 to 11 years. For the USD den...
A director at Dermapharm Holding SE bought 556 shares at 36.066EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.